Evaluation of platinum-free interval and chemotherapeutic effect of subsequent platinum-containing chemotherapy in patients with recurrent ovarian cancer initially treated with bevacizumab: SGSG018/Intergroup studyTamaki Tanaka, Atsushi Hongo, Eiji Kondo et al.|Gynecologic Oncology Reports|2025Cited by 1
#215 Retrospective re-evaluation of platinum-free interval and chemotherapeutic effect against subsequent platinum-containing chemotherapy in recurrent ovarian cancer patients initially treated by chemotherapy with bevacizumabTamaki Tanaka, Atsushi Hongo, Tomoka Usami et al.|International Journal of Gynecological Cancer|2023Cited by 0